Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Losartan as Treatment to Reduce Corneal Scarring Fibrosis
NCT07449000Recruiting
- Sponsor
- Universidad Autónoma de Nuevo León
- Start
- Feb 2026
- Primary completion
- Feb 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in corneal scarring comparing Topical losartan with Placebo (2 arms). Primary endpoint: Best Corrected Visual Acuity at 6 months. Started Feb 2026; status: recruiting.
02
Drugs
losartan
03
Conditions
corneal scarring
Beyond the preview
Go deeper on NCT07449000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07449000.